Sunshine Biopharma SBFM
NASDAQ SBFM
$2.75 +0.04 (+1.48%)
At close: Nov 9, 2026 · 4:00 PM EST

Sunshine Biopharma (SBFM) Acquisitions (2018)

Updated

Sunshine Biopharma (SBFM) reported Acquisitions of $14.35 million for FY2022.

Analysis

Sunshine Biopharma (SBFM) Acquisitions (2018) Analysis & Trends

  • The FY2022 figure ranks as the lowest annual Acquisitions since FY2018.
  • According to Business Quant data, Acquisitions came in at -$4,942 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -17.15 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 10.59 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 19.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Sunshine Biopharma 187,731.50 -38.90 Mn 2.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 -85,231.00
Jun 30, 2018 4,942.00
Mar 31, 2018 75,347.00
API Access

Sunshine Biopharma Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=SBFM&period=max&api_key=YOUR_API_KEY